APSR2026-390

 
Late-Breaking
Submitted
Poster Presentation
 
AP15-001
P109
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1219143-46904-APSR-390_440566.pdf
Format: PDF Only
13. Paediatric Lung Disease
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Boon Yuan Tan * Sultan Ahmad Shah Medical Centre @IIUM Department of Pharmacy Kuantan Malaysia
Muhd Alwi Muhd Helmi - Sultan Ahmad Shah Medical Centre @IIUM Department of Paediatric Kuantan Malaysia
Mohd Helmie Ismail - Sultan Ahmad Shah Medical Centre @IIUM Department of Emergency and Trauma Kuantan Malaysia
Ahmad Fadzil Abdullah - Sultan Ahmad Shah Medical Centre @IIUM Department of Paediatric Kuantan Malaysia
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Boon Yuan
Tan
bryantby@iium.edu.my
+60109031986
31-40
Malaysia
Original Research
Magnesium sulphate infusion in preschool non-asthmatic children with severe acute wheezing.
Maximum 25 words
Abstract Content
Intravenous magnesium sulfate (MgSO₄) is used in severe acute asthma exacerbations. Its efficacy in non-asthmatic acute wheezing remains unclear despite its widespread clinical use. The study is to investigate the effect of MgSO4 infusion on preschool non-asthmatic children with severe acute wheezing.
We conducted a retrospective review of medical records of children aged 6 months to 6 years admitted with severe acute wheezing to the Emergency Department (ED) or paediatric ward at Sultan Ahmad Shah Medical Centre (SASMEC) between 1 January 2019 and 31 December 2024. Data collected included demographic characteristics, prior treatments, and PRESS severity scores before and after MgSO₄ infusion, as well as clinical outcomes. Children with diagnosed asthma, bronchopulmonary dysplasia, or other chronic lung diseases were excluded.
A total of 25 children (19 males, 6 females) received MgSO₄ infusion, with a median age of 2.33 years (IQR 3.17). Diagnoses included bronchopneumonia with bronchospasm (n=16), viral-induced wheeze (including four cases of multi-trigger wheeze) (n= 5), and acute bronchiolitis (n = 4). Eleven children (44%) had a history of atopy, six (24%) were on MDI preventer therapy for recurrent preschool wheeze, and 13 (52%) had smoker parent. MgSO₄ infusion (50 mg/kg) was administered in the ED (n = 15) or paediatric ward (n = 10). There was a significant improvement in the PRESS score, decreasing from 4.0 (IQR 0.0) before treatment to 3.0 (IQR 1.0) after treatment (Z = -3.97, p < 0.005). Clinical outcomes included no patients requiring intubation, 3 requiring BiPAP/CPAP, 14 need HFNC, 8 requiring face mask or nasal oxygen.
MgSO₄ infusion appeared to be associated with clinical improvement in children with severe non-asthmatic acute wheezing. Prospective studies are required to clarify the role of MgSO₄ in this population.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Magnesium sulphate, preschool children, severe wheezing
maximum 3 keywords and no abbreviations, separated by commas
 
289